Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11961359 | 1.00 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL11981760 | 1.00 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL5839806 | 1.00 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL345905 | 1.00 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL345904 | 1.00 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL12060575 | 0.92 | CA2 (0.39) | CA2CA1CA9 | |
| SCHEMBL20367420 | 0.83 | CA1 (0.31) | CA2CA1CA9 | |
| SCHEMBL15678414 | 0.81 | CA2 (0.45) | CA2CA1CA9 | |
| SCHEMBL29525029 | 0.81 | CA1 (0.31) | CA2CA1CA9 | |
| SCHEMBL13592460 | 0.80 | CA2 (0.44) | CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202287-A1 | Stem Cell Culture Methods | ITI SCOTLAND LIMITED (GB) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202287-A1 | Stem Cell Culture Methods | KIT, SOX18, MCL1 | CA2 1970/4885CA1 345/4885CA9 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.